Martin H. Voss

Also affiliated with Cornell University, Kettering University, Freie Universität Berlin

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell Carcinoma

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4058

Top 20%

1.0DataRank

Top 20%23 citations

Renzo G. DiNatale, Phillip M. Rappold, Christopher J. Fong, Francisco Sánchez-Vega, Andrew W. Silagy +15 more

Papers

Driven by 43 papers — median percentile 40. Top paper: “Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) in advanced solid tumours, with an expansion phase in renal, endometrial or bladder cancer”.

Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) in advanced solid tumours, with an expansion phase in renal, endometrial or bladder cancer

British Journal of Cancer(2020)10.1038/s41416-020-01041-x

N/A

2.6DataRank · unranked

90 citations

Michael S. Gordon, Monica Mita, Brian I. Rini, Vicky Makker, Teresa Macarulla +15 more

Comprehensive Genomic Analysis of Translocation Renal Cell Carcinoma Reveals Copy-Number Variations as Drivers of Disease Progression

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3283

N/A

1.9DataRank · unranked

55 citations

Renzo G. DiNatale, Alejandro Sánchez, Ritesh R. Kotecha, Sounak Gupta, Fengshen Kuo +18 more

Everolimus plus bevacizumab is an effective first‐line treatment for patients with advanced papillary variant renal cell carcinoma: Final results from a phase II trial

Cancer(2020)10.1002/cncr.33148

N/A

1.2DataRank · unranked

38 citations

Yasser Ged, Chung‐Han Lee, Andrea Knežević, Ana M. Molina, Ying‐Bei Chen +13 more

High Response Rate and Durability Driven by HLA Genetic Diversity in Patients with Kidney Cancer Treated with Lenvatinib and Pembrolizumab

Molecular Cancer Research(2021)10.1158/1541-7786.mcr-21-0053

N/A

1.2DataRank · unranked

33 citations

Renzo G. DiNatale, Diego Chowell, Chirag Krishna, Vladimir Makarov, Cristina Valero +21 more

Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell Carcinoma

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4058

Top 20%

1.0DataRank

Top 20%23 citations

Renzo G. DiNatale, Phillip M. Rappold, Christopher J. Fong, Francisco Sánchez-Vega, Andrew W. Silagy +15 more

Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

Cell(2022)10.1016/j.cell.2022.01.003

N/A

0.973DataRank · unranked

654 citations

Christopher J. Fong, Anisha Luthra, Shaleigh Smith, Renzo G. DiNatale, Subhiksha Nandakumar +70 more

Treatment-free survival and partitioned survival analysis of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib: 5-year update of CheckMate 214

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-009495

N/A

0.615DataRank · unranked

19 citations

Opeyemi A. Jegede, Elizabeth R. Plimack, Thomas Powles, Robert J. Motzer, Nizar M. Tannir +13 more

Deciphering radiological stable disease to immune checkpoint inhibitors

Annals of Oncology(2022)10.1016/j.annonc.2022.04.450

N/A

0.590DataRank · unranked

50 citations

Song Wu, Hira Rizvi, Q. Zhang, Jacklynn V. Egger, Juan C. Osorio +14 more

Association between neutrophil-to-eosinophil ratio and efficacy outcomes with avelumab plus axitinib or sunitinib in patients with advanced renal cell carcinoma: post hoc analyses from the JAVELIN Renal 101 trial

BMJ Oncology(2024)10.1136/bmjonc-2023-000181

N/A

0.536DataRank · unranked

8 citations

Yu‐Wei Chen, Martin H. Voss, Bradley A. McGregor, Mehmet Asım Bilen, Marc‐Oliver Grimm +9 more

Immunometabolic coevolution defines unique microenvironmental niches in ccRCC

Cell Metabolism(2023)10.1016/j.cmet.2023.06.005

N/A

0.483DataRank · unranked

24 citations

Amy Xie, Eric Minwei Liu, Fengshen Kuo, Min‐Soo Kim, Renzo G. DiNatale +15 more

A Phase 1b/2 Study of Talazoparib and Axitinib in Patients with Advanced Clear-cell Renal Cell Carcinoma

European Urology Oncology(2025)10.1016/j.euo.2025.03.010

N/A

0.104DataRank · unranked

1 citations

Sahil D. Doshi, Andrea Knežević, Rachel Jacobi, Hyung Jun Woo, David H. Aggen +13 more

An evaluation of the role of tumor load in cytoreductive nephrectomy

Canadian Urological Association Journal(2020)10.5489/cuaj.6350

N/A

0.104DataRank · unranked

1 citations

Cihan Düzgöl, Julian Marcon, Renzo G. DiNatale, Roy Mano, Kyle A. Blum +8 more

A robust, trial-agnostic gene signature for response to tyrosine kinase inhibition in ccRRCC.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.4558

N/A

0DataRank · unranked

0 citations

Minwei Liu, Fengshen Kuo, Ritesh R. Kotecha, Chung‐Han Lee, Martin H. Voss +4 more

A Phase 2 Trial of Talazoparib and Avelumab in Genomically Defined Metastatic Kidney Cancer

European Urology Oncology(2023)10.1016/j.euo.2023.10.017

N/A

0DataRank · unranked

15 citations

Sahil D. Doshi, Andrea Knežević, Joshua Chaim, Ying‐Bei Chen, Rachel Jacobi +14 more

Genomic ancestry in kidney cancer: Correlations with clinical and molecular features

Cancer(2023)10.1002/cncr.35074

N/A

0DataRank · unranked

12 citations

Andrea Knežević, Kanika Arora, Chaitanya Bandlamudi, Fengshen Kuo, Maria I. Carlo +12 more

Surgical outcomes of cytoreductive nephrectomy in patients receiving systemic immunotherapy for advanced renal cell carcinoma

Urologic Oncology Seminars and Original Investigations(2023)10.1016/j.urolonc.2023.12.003

N/A

0DataRank · unranked

6 citations

Lennert Eismann, Charlie White, Juan Arroyave Villada, Sari Khaleel, Irina Ostrovnaya +13 more

Data from High Response Rate and Durability Driven by HLA Genetic Diversity in Patients with Kidney Cancer Treated with Lenvatinib and Pembrolizumab

(2023)10.1158/1541-7786.c.6545243

N/A

0DataRank · unranked

2 citations

Renzo G. DiNatale, Diego Chowell, Chirag Krishna, Vladimir Makarov, Cristina Valero +21 more

Associations of diet with survival of patients (pts) with metastatic cancer of the urothelium (mUC) and renal cell carcinoma (mRCC) on immune checkpoint blockade (ICB).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.4598

N/A

0DataRank · unranked

2 citations

Neha Ratna, David Gavrilov, Cihan Düzgöl, Mahnoor Akhlaq, Min Yuen Teo +15 more

Data from Telaglenastat Plus Cabozantinib or Everolimus for Advanced or Metastatic Renal Cell Carcinoma: An Open-Label Phase I Trial

(2023)10.1158/1078-0432.c.6532368.v1

N/A

0DataRank · unranked

0 citations

Nizar M. Tannir, Othon Iliopoulos, Richard J. Lee, Melinda L. Telli, Alice C. Fan +15 more

Data from Associations between Pretreatment Body Composition Features and Clinical Outcomes among Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Blockade

(2023)10.1158/1078-0432.c.6532988.v1

N/A

0DataRank · unranked

0 citations

Alejandro Sánchez, Sujata Patil, Andrea Knežević, Emily Stein, Stacey Petruzella +15 more

Data from Associations between Pretreatment Body Composition Features and Clinical Outcomes among Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Blockade

(2023)10.1158/1078-0432.c.6532988

N/A

0DataRank · unranked

0 citations

Alejandro Sánchez, Sujata Patil, Andrea Knežević, Emily Stein, Stacey Petruzella +15 more

Germline mutations in hereditary renal cell carcinoma (RCC) genes among 32,240 patients with all cancer types.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.4559

N/A

0DataRank · unranked

0 citations

Andrew R. Schroeder, Semanti Mukherjee, Yelena Kemel, Ritesh R. Kotecha, Chung‐Han Lee +12 more

Phase I Study of Everolimus in Combination with Gemcitabine and Split-Dose Cisplatin in Advanced Urothelial Carcinoma

UNC Libraries(2024)10.17615/6gs3-hm85

N/A

0DataRank · unranked

0 citations

Irina Ostrovnaya, Matthew I. Milowsky, Jonathan E. Rosenberg, Wassim Abida, Dean F. Bajorin +6 more

Prospective Study of Patient, Nursing, and Oncology Provider Perspectives on Telemedicine Visits for Renal Cell Carcinoma Clinical Trials

Clinical Genitourinary Cancer(2024)10.1016/j.clgc.2024.102268

N/A

0DataRank · unranked

0 citations

Andrea Knežević, Carlene Gonzalez, Patricia Fischer, ROBERT GOODMAN, Suzanne Gornell +9 more

A phase I/II study of the safety and efficacy of telaglenastat (CB-839) in combination with nivolumab in patients with metastatic melanoma, renal cell carcinoma, and non-small-cell lung cancer

ESMO Open(2025)10.1016/j.esmoop.2025.104536

N/A

0DataRank · unranked

60 citations

Martin H. Voss, Hussein A. Tawbi, Michael S. Gordon, Scott S. Tykodi, Elaine T. Lam +13 more

Identification of therapeutic targets for renal medullary carcinoma via integrated genomic and transcriptomic profiling

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.102423

N/A

0DataRank · unranked

3 citations

Nizar M. Tannir, Funda Meric-Bernstam, Jennifer King, Martin H. Voss, Jessica P Cheng +27 more

Long-term oncologic outcomes of metastatic clear-cell renal cell carcinoma after local therapy alone

Urologic Oncology Seminars and Original Investigations(2025)10.1016/j.urolonc.2025.08.004

N/A

0DataRank · unranked

1 citations

Mark Dawidek, Andrea Knežević, Marc Ganz, Lina Posada, Yash S. Khandwala +13 more

Pathologic Response to Immunotherapy Is Associated with Survival in Patients Undergoing Delayed Nephrectomy for Metastatic Renal Cell Carcinoma

European Urology Oncology(2025)10.1016/j.euo.2025.11.003

N/A

0DataRank · unranked

1 citations

Stephen W. Reese, Burçin Ağrıdağ Üçpınar, Andrea Knežević, Lennert Eismann, Chih‐Ying Wu +14 more

Pathologic Response to Immunotherapy is Associated with Survival in Patients Undergoing Delayed Nephrectomy for Metastatic Renal Cell Carcinoma

medRxiv(2025)10.1101/2025.04.24.25326353

N/A

0DataRank · unranked

0 citations

Stephen W. Reese, Burçin Ağrıdağ Üçpınar, Andrea Knežević, Lennert Eismann, Chih‐Ying Wu +14 more

Phase 1b/2 study of batiraxcept alone and in combination with cabozantinib with or without nivolumab for advanced clear cell renal cell carcinoma

The Oncologist(2025)10.1093/oncolo/oyaf138

N/A

0DataRank · unranked

0 citations

Neil J. Shah, Matthew T. Campbell, Naomi B. Haas, Ariel Ann Nelson, Moshe Chaim Ornstein +12 more

Radiomic biomarkers associated with immune checkpoint blockade response for advanced renal cell carcinoma

Urologic Oncology Seminars and Original Investigations(2025)10.1016/j.urolonc.2025.08.012

N/A

0DataRank · unranked

0 citations

Daniel Barbakoff, Burçin Ağrıdağ Üçpınar, Andrea Knežević, Kelly Fitzgerald, Lennert Eismann +12 more

Supplementary Table 4 from Tumor Genetic Analyses of Patients with Metastatic Renal Cell Carcinoma and Extended Benefit from mTOR Inhibitor Therapy

10.1158/1078-0432.22450608

Top 100%

0DataRank

Top 100%0 citations

A. Ari Hakimi, Can G. Pham, A. Rose Brannon, Ying-Bei Chen, Luis F. Cunha +15 more

A pan-cancer analysis of PBAF complex mutations and their association with immunotherapy response

Nature Communications(2020)10.1038/s41467-020-17965-0

N/A

0DataRank · unranked

66 citations

Kyrollis Attalla, Renzo G. DiNatale, Irina Ostrovnaya, Jessica Flynn, Kyle A. Blum +12 more

Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy

Cancer Cell(2021)10.1016/j.ccell.2021.03.007

N/A

0DataRank · unranked

444 citations

Renzo G. DiNatale, Fengshen Kuo, Raghvendra M. Srivastava, Lynda Vuong, Diego Chowell +28 more

Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic Testing

European Urology Oncology(2021)10.1016/j.euo.2021.09.005

N/A

0DataRank · unranked

39 citations

Rania Sheikh, Ritesh R. Kotecha, Yelena Kemel, Peter A. Reisz, Andrew T. Lenis +22 more

Treatment-free Survival after Immune Checkpoint Inhibitor Therapy versus Targeted Therapy for Advanced Renal Cell Carcinoma: 42-Month Results of the CheckMate 214 Trial

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2283

N/A

0DataRank · unranked

57 citations

Opeyemi A. Jegede, Charlene M. Mantia, Thomas Powles, Lillian Werner, Robert J. Motzer +16 more

Evolving biological associations of upfront cytoreductive nephrectomy in metastatic renal cell carcinoma

Cancer(2021)10.1002/cncr.33790

N/A

0DataRank · unranked

19 citations

Ritesh R. Kotecha, Stanley Weng, Arturo Holmes, Nirmish Singla, Roy Mano +10 more

Genitourinary Medical Oncology Expert Opinion Survey Regarding Treatment Management in the COVID-19 Pandemic

Clinical Genitourinary Cancer(2021)10.1016/j.clgc.2020.12.002

N/A

0DataRank · unranked

2 citations

Darren R. Feldman, Michael J. Morris, Robert J. Motzer, Dana E. Rathkopf, Ashley Marie Regazzi +5 more

A pilot study of preoperative nivolumab in high-risk nonmetastatic renal cell carcinoma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.323

N/A

0DataRank · unranked

5 citations

Kyrollis Attalla, Sujata Patil, Samuel Murray, Ying‐Bei Chen, Ritesh R. Kotecha +5 more

Evaluation of germline genetic testing criteria in early-onset kidney cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.296

N/A

0DataRank · unranked

0 citations

Rania Sheikh, Ritesh R. Kotecha, Yelena Kemel, Aliya Khurram, Peter A. Reisz +15 more

PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine

Nature Immunology(2022)10.1038/s41590-022-01274-3

N/A

0DataRank · unranked

79 citations

David A. Knorr, Laura A. Vella, Luisa Victoria Silva, Lakshmi Chilukuri, Sokratis A. Apostolidis +23 more

Telaglenastat Plus Cabozantinib or Everolimus for Advanced or Metastatic Renal Cell Carcinoma: An Open-Label Phase I Trial

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-2972

N/A

0DataRank · unranked

58 citations

Nizar M. Tannir, Othon Iliopoulos, Richard J. Lee, Melinda L. Telli, Alice C. Fan +15 more

A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma

Cancer Discovery(2022)10.1158/2159-8290.cd-21-0925

N/A

0DataRank · unranked

33 citations

Lynda Vuong, Josef Leibold, Nicholas H. Chakiryan, Michael Curry, Fengshen Kuo +31 more

Martin H. Voss

Indexed papers

Top data-sharing exemplar

Papers